Why the study?
Does low-dose heparin prevent thromboembolism in patients undergoing total hip replacement?
Does low-dose heparin prevent thromboembolism in patients undergoing total hip replacement?
Low-dose subcutaneous heparin failed to adequately prevent deep venous thrombosis and pulmonary embolism in patients undergoing total hip replacement.
No takes yet. Share an insight, caveat, or question.
High VTE rates despite low-dose heparin warrant caution; this case series leaves open optimal prophylaxis in total hip replacement.
C. M. Evarts (1973) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: